REG-Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
Nyxoah’s lead product, Genio, won the Prix Galien UK 2026 Award for Best Medical Technology, recognizing its contribution to treating Obstructive Sleep Apnea. The award highlights the therapy’s impact on patient care and outcomes, reinforcing the company’s position as an innovator in sleep-disordered breathing treatments.
Key figures
- Award name
- Prix Galien UK 2026 Award for Best Medical Technology
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.